Correlation Between Entero Therapeutics, and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Entero Therapeutics, and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entero Therapeutics, and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entero Therapeutics, and Novo Nordisk AS, you can compare the effects of market volatilities on Entero Therapeutics, and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entero Therapeutics, with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entero Therapeutics, and Novo Nordisk.
Diversification Opportunities for Entero Therapeutics, and Novo Nordisk
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Entero and Novo is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Entero Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entero Therapeutics, are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Entero Therapeutics, i.e., Entero Therapeutics, and Novo Nordisk go up and down completely randomly.
Pair Corralation between Entero Therapeutics, and Novo Nordisk
Given the investment horizon of 90 days Entero Therapeutics, is expected to under-perform the Novo Nordisk. In addition to that, Entero Therapeutics, is 5.27 times more volatile than Novo Nordisk AS. It trades about -0.09 of its total potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.02 per unit of volatility. If you would invest 11,847 in Novo Nordisk AS on August 27, 2024 and sell it today you would lose (1,341) from holding Novo Nordisk AS or give up 11.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Entero Therapeutics, vs. Novo Nordisk AS
Performance |
| Timeline |
| Entero Therapeutics, |
| Novo Nordisk AS |
Entero Therapeutics, and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entero Therapeutics, and Novo Nordisk
The main advantage of trading using opposite Entero Therapeutics, and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entero Therapeutics, position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Entero Therapeutics, vs. Cardinal Health | Entero Therapeutics, vs. Inflection Point Acquisition | Entero Therapeutics, vs. Aquestive Therapeutics | Entero Therapeutics, vs. Mangazeya Mining |
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stocks Directory Find actively traded stocks across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |